Study on the Benefit Effect of Valsartan on New-onset Diabetic Nephropathy

唐平,刘丹,杨川,刘珊英,李红辉,王碧飞
DOI: https://doi.org/10.16766/j.cnki.issn.1674-4152.2010.02.045
2010-01-01
Abstract:Objective To explore the effect of valsartan on abnormalities of kidneys of the new-onset diabetic rats.Methods SD rat removed the right kidney were randomly divided into 3 groups:diabetic valsartan treatment group(DV),diabetic non-valsartan treatment group(DM),normal control group(NC).Two weeks later,they were intraperitoneally injected with STZ at 35 mg/kg body weight daily for 3 days to induce diabetes.Valsartan 50 mg/kg body weight was administered through lavage in valsartan treatment group.Samples were obtained in the 8th week after diabetic model successfully established.The samples were measured by biochemistry parameters of blood and urine,renal tissue pathologic and immunohistochemistry.Results The 24 h urine protein was increased,creatinine clearance was reduced,CD68+ macrophages was decreased.After treatment with valsartan,the 24 h urine protein was reduced(P0.05),creatinine clearance was increased(P0.05),CD68+ macrophages was decreased(P0.05).Conclusion Treatment with valsartan may be involved in protection on kidney of new-onset diabetic animals partly via decreasement of CD68+ macrophages.
What problem does this paper attempt to address?